MUTATIONS IN THE P53 GENE ARE NOT LIMITED TO CLASSIC HOT-SPOTS AND ARE NOT PREDICTIVE OF P53 PROTEIN EXPRESSION IN HIGH-GRADE NON-HODGKINS-LYMPHOMA

被引:47
作者
KOCIALKOWSKI, S
PEZZELLA, F
MORRISON, H
JONES, M
LAHA, S
HARRIS, AL
MASON, DY
GATTER, KC
机构
[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,DEPT CELLULAR SCI,LEUKAEMIA RES FUND,IMMUNODIAGNOST UNIT,OXFORD OX3 9DU,ENGLAND
[2] JOHN RADCLIFFE HOSP,IMPERIAL CANC RES FUND,ONCOL MOLEC LAB,OXFORD,ENGLAND
关键词
P53; MUTATIONS; PROTEIN EXPRESSION; NON-HODGKINS LYMPHOMA;
D O I
10.1111/j.1365-2141.1995.tb08911.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have investigated the relationship between the p53 genotype and phenotype in a series of 22 high-grade non-Hodgkin's lymphomas (NHLs) in which we sequenced the p53 gene open reading frame (exons 2-11). Immunostaining for p53 was already available for these cases. Mutations were found in 10/22 cases (45%) and 3/10 were in exons 4 or 10 outside the classic 'hot spot' regions (exons; 5-8). Comparison with immunostaining indicated that, besides cases with the 'expected' patterns (in which gene mutation and protein detection were either both present or both absent) there were also cases in which p53 protein was detected in the absence of any mutation and those with a mutant gene in which the protein was undetectable. These data show that: (1) in high-grade NHLs mutations frequently occur outside the classic hot spot regions and (2) staining for p53 is not predictive of the status of the gene, i.e. whether or not a mutation is present. Therefore in order to document p53 involvement in lymphoid tumours it is necessary both to sequence at least the whole translated open reading frame of the gene and to show evidence of protein expression by immunostaining.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 33 条
  • [1] EVALUATION OF 6 ANTIBODIES FOR IMMUNOHISTOCHEMISTRY OF MUTANT P53 GENE-PRODUCT IN ARCHIVAL COLORECTAL NEOPLASMS
    BAAS, IO
    MULDER, JWR
    OFFERHAUS, GJA
    VOGELSTEIN, B
    HAMILTON, SR
    [J]. JOURNAL OF PATHOLOGY, 1994, 172 (01) : 5 - 12
  • [2] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [3] BODNER SM, 1992, ONCOGENE, V7, P743
  • [4] CESARMAN E, 1993, AM J PATHOL, V143, P845
  • [5] IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES)
    CORDELL, JL
    FALINI, B
    ERBER, WN
    GHOSH, AK
    ABDULAZIZ, Z
    MACDONALD, S
    PULFORD, KAF
    STEIN, H
    MASON, DY
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) : 219 - 229
  • [6] GENETIC-BASIS FOR P53 OVEREXPRESSION IN HUMAN BREAST-CANCER
    DAVIDOFF, AM
    HUMPHREY, PA
    IGLEHART, JD
    MARKS, JR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) : 5006 - 5010
  • [7] DOGLIONI C, 1991, HEMATOL PATHOL, V5, P67
  • [8] P53 MUTATIONS IN HUMAN LYMPHOID MALIGNANCIES - ASSOCIATION WITH BURKITT-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA
    GAIDANO, G
    BALLERINI, P
    GONG, JZ
    INGHIRAMI, G
    NERI, A
    NEWCOMB, EW
    MAGRATH, IT
    KNOWLES, DM
    DALLAFAVERA, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) : 5413 - 5417
  • [9] GANNON JV, 1991, EMBO J, V9, P1595
  • [10] GATTER KC, 1984, RECENT ADV HISTOPATH, P35